Bowel Sounds Summer School is BACK!  In our first Summer School episode this season, hosts Dr. Peter Lu and Dr. Jordan Whatley have taken highlights from past episodes on abdominal pain and put them into a special episode jam-packed with clinical pearls.

Former expert guests Dr. Miguel Saps, Dr. Sam Nurko, Dr. Miranda van Tilburg, Dr. Ann Ming Yeh, Dr. Bruno Chumpitazi, Kirsten Jones, RD, and Dr. Neha Santucci explain to us how they evaluate and treat the child with abdominal pain.

Our Bowel Sounds Summer School series will include four episodes each summer on big topics in our field, artisanally crafted for the ears of learners of all stages from the young student to the seasoned attending.

Learning Objectives:

1. Understand the importance of making a positive diagnosis for a child with an abdominal pain-predominant disorder of gut-brain interaction (DGBI).
2. Recognize the role of lifestyle modification, dietary changes, and supplements in the treatment of children with chronic abdominal pain.
3. Review the behavioral and pharmacological therapies available for children with chronic abdominal pain.

References:

ESPGHAN/NASPGHAN Guidelines for Treatment of Irritable Bowel Syndrome and Functional Abdominal Pain

Featured Episodes:

Miguel Saps - Functional Abdominal Pain

Miranda van Tilburg - Behavioral Treatment of Functional Abdominal Pain

Bruno Chumpitazi & Kirsten Jones - Using the Low-FODMAP Diet for Children with IBS

Neha Santucci - Functional Abdominal Pain in "Organic" GI Diseases

Samuel Nurko - Using Neuromodulator Medications for Functional Abdominal Pain

Ann Ming Yeh - Non-Medication Treatment for Children with Abdominal Pain and Nausea

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, Dr. Jordan Whatley and Dr. Temara Hajjat talk to Dr. Katie Larson-Nath, Pediatric Gastroenterologist and Division Director at the University of Minnesota M Health Fairview Masonic Children’s Hospital, who specializes in pediatric nutrition and leads the Intestinal Rehabilitation Program. We talk about the recently published joint AAP/NASPGHAN Clinical Practice Guideline for Diagnosis and Management of Faltering Weight, a new term that replaces "failure-to-thrive".

Learning objectives

1.     Understand the basis for the change in terminology from “failure-to-thrive” to “faltering weight” per the 2026 joint AAP/NASPGHAN Clinical Practice Guideline

2.     Describe the defining criteria for a diagnosis of faltering weight

3.     Understand the recommended comprehensive evaluation and management of children with faltering weight

Links

Joint AAP/NASPGHAN Clinical Practice Guideline for Diagnosis and Management of Faltering Weight

WHO Weight Gain Velocity Standards

2015 AND/ASPEN Consensus Statement for the Identification and Documentation of Pediatric Malnutrition (Undernutrition)

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this special Bowel Sounds and Nutrition Pearls collaboration episode, hosts Dr. Jennifer Lee and clinical dietitian Nicole Misner talk to Lisa Richardson about the ins and outs of infant formula. This is a must listen episode for all pediatricians, pediatric gastroenterologists, dietitians and anyone who is using or recommending infant formulas. 

Learning Objectives

1. Explain infant formula nutrition, components, and comparison to breast milk
2. Differentiate formula types, ingredients, and clinical use
3. Apply guidance for fomula selection, safety, and caregiver education

Links:

Infant Formula Preparation and Storage | Infant and Toddler Nutrition | CDC

Infant Formula Homepage | FDA

Operation Stork Speed | FDA

Infant Formula References

Larson-Nath C, Bashir A, Herdes RE, et al. Term infant formula macronutrient composition: An update for clinicians. J Pediatr Gastroenterol Nutr. 2025;80(5):751-759. doi:10.1002/jpn3.70002

Rodrigo ML, Tymann HA, Lochen HA, Shores DR. Infant formula ingredients: Updates for clinicians. J Pediatr Gastroenterol Nutr. 2024;78(5):1005-1008. doi:10.1002/jpn3.12192

Lewis JI, Dror DK, Hampel D, et al. Reference Values for Macronutrients in Human Milk: the Mothers, Infants and Lactation Quality (MILQ) Study. Adv Nutr. 2025;16 Suppl 1(Suppl 1):10050. doi:10.1016/j.advnut.2025.100501

Taylor SN, Buck CO. Post-discharge nutrition to optimize preterm infant short- and long-term outcomes. Semin Fetal Neonatal Med. 2025;30(2):101637. doi:10.1016/j.siny.2025.101637

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, Drs. Jason Silverman and Amber Hildreth talk to Dr. Valeria Cohran about the advances in intestinal rehabilitation care for infants and children with short bowel syndrome including changes nutrition management, line care and use of GLP-2 analogues that have led to decreases in intestinal failure associated liver disease and transplantation. 

Learning objectives

1. To understand the composition and impact of multidisciplinary intestinal rehabilitation teams.
2. To review the historical presentation of intestinal failure-associated liver disease (IFALD) and changes in practice that have reduced its prevalence and severity.
3. To review GLP-2 analogues and their impact on outcomes and quality of life for children with short bowel syndrome. 

Links

Papers mentioned:

1. PIFCON data paper on IFALD
2. Cholestasis and infection in long-term PN
3. Management of CVL in SBS Position Paper
4. Intestinal Rehabilitation Teams Practice Guideline

Previous episodes mentioned:

1. Sue Protheroe - Enteral Nutrition in Intestinal Failure
2. Danielle Wendel - Central Line Management in Intestinal Failure (Special JPGN Episode)
3. Ruben Quiros-Tejeira - Multivisceral Transplantation
4. Paul Wales - Surgical Management in Short Bowel Syndrome
5. Valeria Cohran & Conrad Cole - Racism in Medicine

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat and Dr. Peter Lu talk to Dr. Maureen Leonard, a pediatric gastroenterologist and Associate Professor at Massachusetts General Hospital. 

Dr. Leonard discusses the latest research on early life factors that can increase celiac disease risk for susceptible children, including potentially modifiable risk factors. 

Dr. Leonard's disclosures include:  Consultant for Takeda, Chugai, Anokion, Sonoma, and Interlude Biopharma and research support from Takeda, Pfizer, Regeneron, Moderna, and Mead Johnson Nutrition.

Learning objectives

• Understand early life determinants for celiac disease
• Understand environmental influences on developing celiac disease

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode of Bowel Sounds, hosts Drs. Amber Hildreth and Jennifer Lee talk to Dr. Elizabeth Rand, a pediatric gastroenterologist in the Division of Gastroenterology, Hepatology and Nutrition at Children's Hospital of Philadelphia (CHOP), Medical Director of CHOP's Liver Transplant Program, Director of the Gastroenterology Fellowship Program and Director of the Advanced Transplant Hepatology Program. We talk everything about Fontan Associated Liver Disease (FALD), from diagnosis to management and future research opportunities in the field. 

Learning objectives

1. Describe the pathophysiology of FALD
2. Understand the management challenges in patients with FALD
3. Explore the unanswered questions about FALD to help guide future research priorities 

Links:

Single-cell multiomics guided mechanistic understanding of Fontan-associated liver disease

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode of Bowel Sounds, hosts Dr. Peter Lu and Dr. Jason Silverman talk to Dr. Leonel Rodriguez, Chief of Pediatric Gastroenterology and Professor of Pediatrics at Yale Medicine. We discuss the rising number of children presenting to us with the inability to belch and the relatively new diagnosis of retrograde cricopharyngeal dysfunction (R-CPD).

Learning objectives

• Recognize the presenting symptoms of retrograde cricopharyngeal dysfunction (R-CPD) and its potential overlap with disorders of gut-brain interaction.
• Understand the evaluation of a child with an inability to belch and the utility of esophageal manometry.
• Review the management of R-CPD, including the potential role of less invasive treatment options prior to cricopharyngeal Botox injection.

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, Dr. Jordan Whatley and Dr. Amber Hildreth talk to Dr. Pete Duncan, Pediatric Gastroenterologist at Boston Children's Hospital who specializes in Aerodigestive Medicine and leads the NASPGHAN Aerodigestive Special Interest Group. We talk about the evaluation and management of oropharyngeal dysphagia and aspiration in children and how the approach to these issues has changed over time. 

Learning objectives

1.     Understand normal swallowing function and the phases involved

2.     Describe the causes of dysphagia in each phase of swallowing

3.     Understand the evaluation and management of children with oropharyngeal dysphagia

Links

https://www.iddsi.org/standards/framework

https://www.childrenshospital.org/services/aerodigestive-center

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, Drs. Jason Silverman and Jennifer Lee talk to Dr. Douglas Fishman about mitigating risk of endoscopy.  This episode reviews the 2019 NASPGHAN guidelines on high-risk pediatric endoscopy, with a practical focus on risk mitigation and safety. A must-listen for clinicians performing diagnostic endoscopy, offering real-world strategies for managing complex cases. 

Learning objectives

1. Explain endoscopy risks and mitigation strategies in children
2. Apply the 2019 High Risk Endoscopy NASPGHAN guidelines to pediatric endoscopy scenarios
3. Evaluate patient-specific factors influencing endoscopy safety

Links

Papers mentioned:

Pediatric_Endoscopy_and_High_risk_Patients__A.26.pdf

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode of Bowel Sounds, hosts Drs. Amber Hildreth and Jason Silverman talk to Dr. Saul Karpen, the inaugural chief scientific officer for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, Richmond, Va., where he is a professor of internal medicine and adjunct professor in pediatric medicine at the VCU School of Medicine. We talk about new genetic discoveries in biliary atresia and the future goals of research on this important pediatric liver topic.

Learning objectives

1. Describe the pathophysiology of biliary atresia 
2. Understand the importance of early screening and new tools to assist in early detection 
3. Examine the newly discovered genetic etiology to biliary atresia

Links:

Guidance for the Primary Care Provider in Identifying Infants with Biliary Atresia by 2-4 Weeks of Life: Clinical Report

Bilitool.org

Liver-Restricted Deletion of the Biliary Atresia Candidate Gene PKD1L1 Causes Bile Duct Dysmorphogenesis and Ciliopathy

Stravitz-Sanyal Institute for Liver Disease and Metabolic Health

AASLD

Previous Episodes Mentioned:

Bill Balistreri- Neonatal Cholestasis

Jorge Bezerra- Advances in Biliary Atresia

Disclosures:

Dr. Karpen has a non-reimbursed consulting relationship with Ipsen as BOLD PI

Dr. Hildreth serves as a consultant and speaker for Ipsen

Send us Fan Mail

Support the show

This episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.